Resubmitting with updated rationale as per rejection:
All pharmacotherapy for osteoporosis are used to decrease fracture risk. Osteoporosis is largely asymptomatic and the goal of treatment is measured by the liklihood of prevented fracture.
Because of this, the card is ineffective in its current form, as it implies there may be other goals for treatment in osteoporosis, or that other medications may treat osteoporosis through means other than reducing fracture risk or that Teriperatide is unique in this goal of treatment.
My new recommendation is that the card be changed to the following to help students understand that there is only one goal in treatment of osteoporosis, and that is to decrease fracture risk.
see links for uptodate and amboss:
https://www.uptodate.com/contents/bisphosphonate-therapy-for-the-treatment-of-osteoporosis?search=osteoporosis%20treatment&source=search_result&selectedTitle=3%7E150&usage_type=default&display_rank=3
https://next.amboss.com/us/article/cT0ap2?q=osteoporosis